Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2014; 20(1): 183-192
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.183
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.183
Table 1 Clinicopathological characteristics of hepatocellular carcinoma patients n (%)
Characteristics | Patients |
Total | 213 (100) |
Age (yr)a | |
< 49 | 105 (49.3) |
≥ 49 | 108 (50.7) |
Sex | |
Female | 17 (8.0) |
Male | 196 (92.0) |
Grade | |
I | 19 (8.9) |
II | 97 (45.5) |
III | 91 (42.7) |
IV | 6 (2.8) |
Stage | |
I + II | 174 (81.7) |
III + IV | 39 (18.3) |
Relapse | |
No | 83 (39.0) |
Yes | 130 (61.0) |
AFP (ng/mL) | |
< 400 | 125 (58.7) |
≥ 400 | 88 (41.3) |
Child-Pugh classification | |
A | 195 (91.5) |
B | 16 (7.5) |
C | 2 (0.9) |
HBV DNA | |
Positive | 113 (53.1) |
Negative | 100 (46.9) |
Postoperative platelet count | |
< 100 × 109/L | 35 (16.4) |
≥ 100 × 109/L | 178 (83.6) |
-
Citation: Jia SW, Fu S, Wang F, Shao Q, Huang HB, Shao JY.
ALK gene copy number gain and its clinical significance in hepatocellular carcinoma. World J Gastroenterol 2014; 20(1): 183-192 - URL: https://www.wjgnet.com/1007-9327/full/v20/i1/183.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i1.183